https://www.marketscreener.com/quote/stock/IMMUNOMEDICS-INC-9671/news/Immunomedics-Reports-Sacituzumab-Govitecan-IMMU-132-Shows-Significant-Clinical-Activity-in-Metasta-22195648/?utm_source=telegram&utm_medium=social&utm_campaign=share